Trial intelligence / Profile preview

Perioperative complications in obese and non-obese patients

DRKS00004776Phase 3Completed

Sponsor
Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus Dresden
Start
Aug 2013
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of linezolid, meropenem, tigecycline, cefazolin, metronidazole and 4 more in surgical site infection (SSI) and postoperative pain (8 arms), sponsored by Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus Dresden. Primary endpoints: Perioperative tissue concentrations of antibiotics and Perioperative tissue concentrations of analgesics. Started Aug 2013; status: completed.

02

Drugs

linezolidmeropenemtigecyclinecefazolinmetronidazole
03

Conditions

surgical site infection (SSI)postoperative pain

Beyond the preview

Go deeper on DRKS00004776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00004776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call